secwatch.observer — SEC 8-K summary
======================================

Issuer:     Astrana Health, Inc. (ASTH)
CIK:        0001083446
Form:       8-K
Filed at:   2023-05-08T23:59:59+00:00
Accession:  0001628280-23-016464
Event type: earnings
Sentiment:  neutral
Materiality: 0.65
Item codes: 2.02, 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

ApolloMed Q1 revenue $337M (+28% YoY), EPS $0.31 flat; appoints Chan Basho CFO
------------------------------------------------------------------------------

- Q1 revenue $337.2M (+28% YoY), net income attributable $14.6M (+3%), diluted EPS $0.31 (flat YoY).
- Adjusted EBITDA $29.8M vs $34.4M, decrease driven by higher investments and non-cash gains.
- Chan Basho appointed permanent CFO (was interim); will remain Chief Strategy Officer.
- Acquired For Your Benefit (FYB) and received CA DMHC approval for Knox-Keene health plan, enabling global risk assumption.
- Reaffirms FY23 guidance: revenue $1.3B-$1.5B, net income $49.5M-$71.5M, adj EBITDA $120M-$160M, EPS $0.95-$1.20.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1083446/000162828023016464/0001628280-23-016464-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1083446/000162828023016464/ameh-20230505.htm
  HTML page:      https://secwatch.observer/filing/0001628280-23-016464

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer